...can brag of gains in their stock in 2008, but ViroPharma joined other biotech stocks like Gilead Sciences (Nasdaq: GILD) and Amgen (Nasdaq: AMGN) in this class. The key is plenty of cash flowing into the firm's coffers, making ViroPharma a cash-rich small...
• Pharma News
Powered By DaylifeOther company news pages:
- Abbott Labs
- Amgen
- AstraZeneca
- Bristol-Myers Squibb
- Eli Lilly
- Glaxo
- Roche
- J&J
- Merck
- Novartis
- Pfizer
- Sanofi-Aventis
- Schering-Plough
- Wyeth
Amgen News
Who's up for some Pfizer matchmaking?
...to boot. As you know, Deutsche Bank's Barbara Ryan has pointed out a series of possible targets for Pfizer, the latest being Amgen and penultimate being Bristol. Cramer himself recently nominated Allergan. As BNet says, if enough people throw out enough possible...
Patrick McCarty joins OUCH
...experience," Tamayo said. "He's done the Giro d'Italia a couple times and he was instrumental in helping Floyd win the 2006 Amgen Tour of California with Phonak. He's going to be a real asset to the team for races like California and Missouri, as well as many...
Pfizer Goes Shopping and Water Is Wet: News at 11!
...And investors should expect nothing less. Whether the purchase is a relatively large company like Gilead Sciences (Nasdaq: GILD), Amgen (Nasdaq: AMGN), or even Wyeth (NYSE: WYE) or a series of smaller acquisitions like GlaxoSmithKline (NYSE: GSK) announced...
Level of FDA drug approvals in '08 called disappointing
...for other uses. Loss monitors the FDA for the consulting firm Washington Analysis. Among the new medicines were Nplate from Amgen Inc., the world's largest biotechnology company, to treat a bleeding disorder afflicting 60,000 Americans. GlaxoSmithKline Plc...
Gilead Sciences Is Go-To Stock For Top Funds
...was in a confirmed rally. Top funds have been adding medical and biotech issues such as Gilead Sciences (GILD), Genentech (DNA), Amgen (AMGN) and Onyx Pharmaceuticals (ONXX) as of their latest reporting periods. Discount retailers Wal-Mart (WMT) and Costco...
Obesity: Reviving the promise of leptin
...million for commercial rights to recombinant human leptin, a record amount for a deal with an academic institution. In 2006, Amgen sold the rights to Amylin Pharmaceuticals (San Diego). Amylin is testing leptin in combination with its diabetes drug, pramlintide. The...
Nasdaq Market Wrap - 5 Jan 2009
...of screening are: Apple Computer Inc (AAPL), Adobe Systems (ADBE), Akamai Technologies Inc (AKAM), Applied Materials Inc. (AMAT), Amgen Inc (AMGN), Amazon.com, Inc. (AMZN), Broadcom (BRCM), Comcast Corp (CMCSA), Costco Wholesale Corp. (COST), Cisco Systems(CSCO),Dell...
Pfizer seeks pharma deal: report
...grow revenues . . . We are open to opportunities and constantly looking at those which are big, small and inbetween.'" FT suggested Amgen, the largest U.S. biotech developer, as a likely candidate. Because your contributions are currently under review, no...
Pfizer sees acquisitions as good medicine
...the possibility that he'll target a large rival and pull off a game-changing merger. One of those names being bandied about is Amgen Inc., the large U.S.-based biotechnology company, which Amgen shareholders have previously urged Pfizer to scoop up. - George...
Clear
Clear